General approach for the calculation of tissue to plasma partition coefficients.

A new mechanistic, universal model for the calculation of steady state tissue:plasma partition coefficients (Kt:p) of organic chemicals in mammalian species was developed. The approach allows the estimation of Kt:p-values based on the composition of the tissues in terms of water, neutral lipids, neutral and acidic phospholipids and proteins using the lipophilicity, the binding to phospholipid membranes, the pKa and the unbound fraction in blood plasma as compound specific parameters. Taking explicitly into account the sign and fraction of the charge of the compounds at the physiological pH the method is universally applicable to neutral, acidic, basic or multiply charged substances and has thus a significantly extended applicability compared to previously published approaches. The model was applied to 59 chemically diverse drug compounds for which tissue:plasma partition coefficients are reported in the literature. In total 474 experimentally observed Kt:p values for 12 tissues and the red blood cells were available and could be compared to model results. For 73% of the calculated values a deviation less than 3-fold from the respective observed value was found, proving the validity of the approach.

[1]  片木 敏行 2,4-D誘導体のホスファチジルコリン多重層リポソームへの分配 , 2001 .

[2]  F. Theil,et al.  A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.

[3]  H. Sasabe,et al.  Carrier-mediated hepatic uptake of quinolone antibiotics in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[4]  B. Corkey,et al.  Intracellular pH in adipocytes: effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Wunderli-Allenspach,et al.  Partition behaviour of acids and bases in a phosphatidylcholine liposome–buffer equilibrium dialysis system , 1997 .

[6]  J. DeJongh,et al.  A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans , 1997, Archives of Toxicology.

[7]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[8]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  A. Malan,et al.  Intracellular pH in hibernation and respiratory acidosis in the European hamster , 2004, Journal of Comparative Physiology B.

[10]  P. Simkowitz,et al.  1-Anilino-8-naphthalenesulfonate: A fluorescent probe of ion and ionophore transport kinetics and trans-membrane asymmetry , 1977, The Journal of Membrane Biology.

[11]  Jörg Keldenich,et al.  Multilamellar Liposomes and Solid-Supported Lipid Membranes (TRANSIL): Screening of Lipid-Water Partitioning Toward a High-Throughput Scale , 2001, Pharmaceutical Research.

[12]  S. Wood,et al.  Regulation of intracellular pH in lungs and other tissues during hypercapnia. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[13]  M. Rowland,et al.  Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. , 2005, Journal of pharmaceutical sciences.

[14]  Beate I. Escher,et al.  Partitioning of Substituted Phenols in Liposome−Water, Biomembrane−Water, and Octanol−Water Systems , 1996 .

[15]  L. Dory,et al.  Interstitial fluid lipoproteins. , 1987, Journal of lipid research.

[16]  T. Terasaki,et al.  Physiologically Based Pharmacokinetic Model for β-Lactam Antibiotics I: Tissue Distribution and Elimanation Rates , 1983 .

[17]  N. Gómez,et al.  Lung lipid composition in zinc-deficient rats , 2002, Lipids.

[18]  D. Levitt,et al.  The pharmacokinetics of the interstitial space in humans , 2003, BMC clinical pharmacology.

[19]  F. Theil,et al.  Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. , 2001, Journal of pharmaceutical sciences.

[20]  D Mackay,et al.  A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.

[21]  L. Schanker,et al.  Lung pH and pulmonary absorption of nonvolatile drugs in the rat. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[22]  Graham Lawson,et al.  Pharmacokinetics of Midazolam in Neonates Undergoing Extracorporeal Membrane Oxygenation , 2003, Anesthesiology.

[23]  E. Nakashima,et al.  Relationships in the Structure–Tissue Distribution of Basic Drugs in the Rabbit , 1990, Pharmaceutical Research.

[24]  D. Harrison,et al.  Micro‐electrode measurement of skin pH in humans during ischaemia, hypoxia and local hypothermia. , 1979, The Journal of physiology.

[25]  L. Aarons,et al.  Quantitative Structure–Pharmacokinetics Relationships: II. A Mechanistically Based Model to Evaluate the Relationship Between Tissue Distribution Parameters and Compound Lipophilicity , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[26]  Effect of phosphatidylserine content on the partition coefficients of diazepam and flurazepam between phosphatidylcholine-phosphatidylserine bilayer of small unilamellar vesicles and water studied by second derivative spectrophotometry. , 2002, Chemical & pharmaceutical bulletin.

[27]  M. Rowland,et al.  Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. , 2006, Journal of pharmaceutical sciences.

[28]  R. Braddock,et al.  Prediction of the partition coefficient of lipophilic compounds in the air-mammal tissue system. , 1993, The Science of the total environment.

[29]  T. Murakami,et al.  Phosphatidylserine as a Determinant for the Tissue Distribution of Weakly Basic Drugs in Rats , 1990, Pharmaceutical Research.

[30]  M Pelekis,et al.  An Approach for Incorporating Tissue Composition Data Into Physiologically Based Pharmacokinetic Models , 1995, Toxicology and industrial health.

[31]  Malcolm Rowland,et al.  Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. , 2005, Journal of pharmaceutical sciences.

[32]  H. B. Matthews,et al.  Using Structural Information to Create Physiologically Based Pharmacokinetic Models for All Polychlorinated Biphenyls: I. Tissue:Blood Partition Coefficients , 1997 .

[33]  B. Müller,et al.  Determination of liposome partitioning of ionizable drugs by titration. , 1999, Journal of pharmaceutical sciences.

[34]  R. E. Ellis,et al.  Reference Man: Anatomical, Physiological and Metabolic Characteristics. Report of the Task Group on Reference Man ICRP Publication 23 , 1976 .

[35]  Viera Lukacova,et al.  A Model‐based Dependence of the Human Tissue/Blood Partition Coefficients of Chemicals on Lipophilicity and Tissue Composition , 1999 .

[36]  I. Nestorov,et al.  Development of a Whole Body Physiologically Based Model to Characterise the Pharmacokinetics of Benzodiazepines. 1: Estimation of Rat Tissue-Plasma Partition Ratios , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[37]  Kannan Krishnan,et al.  Molecular Structure-Based Prediction of the Partition Coefficients of Organic Chemicals for Physiological Pharmacokinetic Models , 1996 .